Springe zum Inhalt
| Eingeschlossene Patienten: 19.906 (Stand 01. Oktober 2020) | |
| Amgevita® (Adalimumab) | 94 |
| Benepali® (Etanercept) | 737 |
| Cimzia® (Certolizumab) | 939 |
| Enbrel® (Etanercept) | 2865 |
| Erelzi® (Etanercept) | 293 |
| Flixabi® (Infliximab) | 8 |
| Hulio® (Adalimumab) | 50 |
| Humira® (Adalimumab) | 2903 |
| Hyrimoz® (Adalimumab) | 69 |
| Idacio® (Adalimumab) | 9 |
| Imraldi® (Adalimumab) | 91 |
| Inflectra™ (Infliximab) | 16 |
| Kevzara® (Sarilumab) | 142 |
| Kineret® (Anakinra) | 89 |
| MabThera® (Rituximab) | 1458 |
| Olumiant® (Baricitinib) | 415 |
| Orencia® (Abatacept) | 846 |
| Remicade® (Infliximab) | 762 |
| Remsima® (Infliximab) | 11 |
| Rinvoq® (Upadacitinib) | 75 |
| Rixathon® (Rituximab) | 14 |
| RoActemra® (Tocilizumab) | 1330 |
| Simponi® (Golimumab) | 446 |
| Xeljanz® (Tofacitinib) | 308 |
| Zessly® (Infliximab) | 2 |
| Kontrollen | 5934 |
